Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.
Identifieur interne : 001C36 ( PubMed/Checkpoint ); précédent : 001C35; suivant : 001C37Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.
Auteurs : S-Q Wang [République populaire de Chine] ; Q-S Du ; K. Zhao ; A-X Li ; D-Q Wei ; K-C ChouSource :
- Amino acids [ 1438-2199 ] ; 2007.
Descripteurs français
- KwdFr :
- Algorithmes, Bases de données factuelles, Cathepsine L, Cathepsines (antagonistes et inhibiteurs), Conformation moléculaire, Cysteine endopeptidases, Humains, Inhibiteurs de protéases (), Inhibiteurs de protéases (pharmacologie), Modèles moléculaires, Médicaments issus de plantes chinoises (), Médicaments issus de plantes chinoises (pharmacologie), Proenzymes (antagonistes et inhibiteurs), Préparations à base de plantes (), Préparations à base de plantes (pharmacologie), Simulation numérique, Structure moléculaire, Syndrome respiratoire aigu sévère (traitement médicamenteux), Évaluation préclinique de médicament.
- MESH :
- antagonistes et inhibiteurs : Cathepsines, Proenzymes.
- pharmacologie : Inhibiteurs de protéases, Médicaments issus de plantes chinoises, Préparations à base de plantes.
- traitement médicamenteux : Syndrome respiratoire aigu sévère.
- Algorithmes, Bases de données factuelles, Cathepsine L, Conformation moléculaire, Cysteine endopeptidases, Humains, Inhibiteurs de protéases, Modèles moléculaires, Médicaments issus de plantes chinoises, Préparations à base de plantes, Simulation numérique, Structure moléculaire, Évaluation préclinique de médicament.
English descriptors
- KwdEn :
- Algorithms, Cathepsin L, Cathepsins (antagonists & inhibitors), Computer Simulation, Cysteine Endopeptidases, Databases, Factual, Drug Evaluation, Preclinical, Drugs, Chinese Herbal (chemistry), Drugs, Chinese Herbal (pharmacology), Enzyme Precursors (antagonists & inhibitors), Humans, Models, Molecular, Molecular Conformation, Molecular Structure, Plant Preparations (chemistry), Plant Preparations (pharmacology), Protease Inhibitors (chemistry), Protease Inhibitors (pharmacology), Severe Acute Respiratory Syndrome (drug therapy).
- MESH :
- chemical , antagonists & inhibitors : Cathepsins, Enzyme Precursors.
- chemical , chemistry : Drugs, Chinese Herbal, Plant Preparations, Protease Inhibitors.
- chemical , pharmacology : Drugs, Chinese Herbal, Plant Preparations, Protease Inhibitors.
- chemical : Cathepsin L, Cysteine Endopeptidases.
- drug therapy : Severe Acute Respiratory Syndrome.
- Algorithms, Computer Simulation, Databases, Factual, Drug Evaluation, Preclinical, Humans, Models, Molecular, Molecular Conformation, Molecular Structure.
Abstract
Recently Simmons et al. reported a new mechanism for SARS virus entry into target cells, where MDL28170 was identified as an efficient inhibitor of CTSL-meditated substrate cleavage with IC(50) of 2.5 nmol/l. Based on the molecule fingerprint searching method, 11 natural molecules were found in the Traditional Chinese Medicines Database (TCMD). Molecular simulation indicates that the MOL376 (a compound derived from a Chinese medicine herb with the therapeutic efficacy on the human body such as relieving cough, removing the phlegm, and relieving asthma) has not only the highest binding energy with the receptor but also the good match in geometric conformation. It was observed through docking studies that the van der Waals interactions made substantial contributions to the affinity, and that the receptor active pocket was too large for MDL21870 but more suitable for MOL736. Accordingly, MOL736 might possibly become a promising lead compound for CTSL inhibition for SARS therapy.
DOI: 10.1007/s00726-006-0403-1
PubMed: 16998715
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:16998715Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.</title><author><name sortKey="Wang, S Q" sort="Wang, S Q" uniqKey="Wang S" first="S-Q" last="Wang">S-Q Wang</name><affiliation wicri:level="3"><nlm:affiliation>College of Pharmaceuticals and Biotechnology, Tianjin University, Tianjin, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>College of Pharmaceuticals and Biotechnology, Tianjin University, Tianjin</wicri:regionArea><placeName><settlement type="city">Tianjin</settlement></placeName></affiliation></author><author><name sortKey="Du, Q S" sort="Du, Q S" uniqKey="Du Q" first="Q-S" last="Du">Q-S Du</name></author><author><name sortKey="Zhao, K" sort="Zhao, K" uniqKey="Zhao K" first="K" last="Zhao">K. Zhao</name></author><author><name sortKey="Li, A X" sort="Li, A X" uniqKey="Li A" first="A-X" last="Li">A-X Li</name></author><author><name sortKey="Wei, D Q" sort="Wei, D Q" uniqKey="Wei D" first="D-Q" last="Wei">D-Q Wei</name></author><author><name sortKey="Chou, K C" sort="Chou, K C" uniqKey="Chou K" first="K-C" last="Chou">K-C Chou</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:16998715</idno><idno type="pmid">16998715</idno><idno type="doi">10.1007/s00726-006-0403-1</idno><idno type="wicri:Area/PubMed/Corpus">002081</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002081</idno><idno type="wicri:Area/PubMed/Curation">002081</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002081</idno><idno type="wicri:Area/PubMed/Checkpoint">001C36</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C36</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.</title><author><name sortKey="Wang, S Q" sort="Wang, S Q" uniqKey="Wang S" first="S-Q" last="Wang">S-Q Wang</name><affiliation wicri:level="3"><nlm:affiliation>College of Pharmaceuticals and Biotechnology, Tianjin University, Tianjin, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>College of Pharmaceuticals and Biotechnology, Tianjin University, Tianjin</wicri:regionArea><placeName><settlement type="city">Tianjin</settlement></placeName></affiliation></author><author><name sortKey="Du, Q S" sort="Du, Q S" uniqKey="Du Q" first="Q-S" last="Du">Q-S Du</name></author><author><name sortKey="Zhao, K" sort="Zhao, K" uniqKey="Zhao K" first="K" last="Zhao">K. Zhao</name></author><author><name sortKey="Li, A X" sort="Li, A X" uniqKey="Li A" first="A-X" last="Li">A-X Li</name></author><author><name sortKey="Wei, D Q" sort="Wei, D Q" uniqKey="Wei D" first="D-Q" last="Wei">D-Q Wei</name></author><author><name sortKey="Chou, K C" sort="Chou, K C" uniqKey="Chou K" first="K-C" last="Chou">K-C Chou</name></author></analytic><series><title level="j">Amino acids</title><idno type="eISSN">1438-2199</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Algorithms</term><term>Cathepsin L</term><term>Cathepsins (antagonists & inhibitors)</term><term>Computer Simulation</term><term>Cysteine Endopeptidases</term><term>Databases, Factual</term><term>Drug Evaluation, Preclinical</term><term>Drugs, Chinese Herbal (chemistry)</term><term>Drugs, Chinese Herbal (pharmacology)</term><term>Enzyme Precursors (antagonists & inhibitors)</term><term>Humans</term><term>Models, Molecular</term><term>Molecular Conformation</term><term>Molecular Structure</term><term>Plant Preparations (chemistry)</term><term>Plant Preparations (pharmacology)</term><term>Protease Inhibitors (chemistry)</term><term>Protease Inhibitors (pharmacology)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Algorithmes</term><term>Bases de données factuelles</term><term>Cathepsine L</term><term>Cathepsines (antagonistes et inhibiteurs)</term><term>Conformation moléculaire</term><term>Cysteine endopeptidases</term><term>Humains</term><term>Inhibiteurs de protéases ()</term><term>Inhibiteurs de protéases (pharmacologie)</term><term>Modèles moléculaires</term><term>Médicaments issus de plantes chinoises ()</term><term>Médicaments issus de plantes chinoises (pharmacologie)</term><term>Proenzymes (antagonistes et inhibiteurs)</term><term>Préparations à base de plantes ()</term><term>Préparations à base de plantes (pharmacologie)</term><term>Simulation numérique</term><term>Structure moléculaire</term><term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term><term>Évaluation préclinique de médicament</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Cathepsins</term><term>Enzyme Precursors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Drugs, Chinese Herbal</term><term>Plant Preparations</term><term>Protease Inhibitors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Drugs, Chinese Herbal</term><term>Plant Preparations</term><term>Protease Inhibitors</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Cathepsin L</term><term>Cysteine Endopeptidases</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Cathepsines</term><term>Proenzymes</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Inhibiteurs de protéases</term><term>Médicaments issus de plantes chinoises</term><term>Préparations à base de plantes</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Algorithms</term><term>Computer Simulation</term><term>Databases, Factual</term><term>Drug Evaluation, Preclinical</term><term>Humans</term><term>Models, Molecular</term><term>Molecular Conformation</term><term>Molecular Structure</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Algorithmes</term><term>Bases de données factuelles</term><term>Cathepsine L</term><term>Conformation moléculaire</term><term>Cysteine endopeptidases</term><term>Humains</term><term>Inhibiteurs de protéases</term><term>Modèles moléculaires</term><term>Médicaments issus de plantes chinoises</term><term>Préparations à base de plantes</term><term>Simulation numérique</term><term>Structure moléculaire</term><term>Évaluation préclinique de médicament</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Recently Simmons et al. reported a new mechanism for SARS virus entry into target cells, where MDL28170 was identified as an efficient inhibitor of CTSL-meditated substrate cleavage with IC(50) of 2.5 nmol/l. Based on the molecule fingerprint searching method, 11 natural molecules were found in the Traditional Chinese Medicines Database (TCMD). Molecular simulation indicates that the MOL376 (a compound derived from a Chinese medicine herb with the therapeutic efficacy on the human body such as relieving cough, removing the phlegm, and relieving asthma) has not only the highest binding energy with the receptor but also the good match in geometric conformation. It was observed through docking studies that the van der Waals interactions made substantial contributions to the affinity, and that the receptor active pocket was too large for MDL21870 but more suitable for MOL736. Accordingly, MOL736 might possibly become a promising lead compound for CTSL inhibition for SARS therapy.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16998715</PMID><DateCompleted><Year>2008</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-2199</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2007</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Amino acids</Title><ISOAbbreviation>Amino Acids</ISOAbbreviation></Journal><ArticleTitle>Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.</ArticleTitle><Pagination><MedlinePgn>129-35</MedlinePgn></Pagination><Abstract><AbstractText>Recently Simmons et al. reported a new mechanism for SARS virus entry into target cells, where MDL28170 was identified as an efficient inhibitor of CTSL-meditated substrate cleavage with IC(50) of 2.5 nmol/l. Based on the molecule fingerprint searching method, 11 natural molecules were found in the Traditional Chinese Medicines Database (TCMD). Molecular simulation indicates that the MOL376 (a compound derived from a Chinese medicine herb with the therapeutic efficacy on the human body such as relieving cough, removing the phlegm, and relieving asthma) has not only the highest binding energy with the receptor but also the good match in geometric conformation. It was observed through docking studies that the van der Waals interactions made substantial contributions to the affinity, and that the receptor active pocket was too large for MDL21870 but more suitable for MOL736. Accordingly, MOL736 might possibly become a promising lead compound for CTSL inhibition for SARS therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>S-Q</ForeName><Initials>SQ</Initials><AffiliationInfo><Affiliation>College of Pharmaceuticals and Biotechnology, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Q-S</ForeName><Initials>QS</Initials></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>A-X</ForeName><Initials>AX</Initials></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>D-Q</ForeName><Initials>DQ</Initials></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>K-C</ForeName><Initials>KC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Amino Acids</MedlineTA><NlmUniqueID>9200312</NlmUniqueID><ISSNLinking>0939-4451</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004792">Enzyme Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028321">Plant Preparations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D002403">Cathepsins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.15</RegistryNumber><NameOfSubstance UI="C534281">CTSL protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.15</RegistryNumber><NameOfSubstance UI="D056668">Cathepsin L</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056668" MajorTopicYN="N">Cathepsin L</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002403" MajorTopicYN="N">Cathepsins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004365" MajorTopicYN="N">Drugs, Chinese Herbal</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004792" MajorTopicYN="N">Enzyme Precursors</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028321" MajorTopicYN="N">Plant Preparations</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>08</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>9</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>2</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>9</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16998715</ArticleId><ArticleId IdType="doi">10.1007/s00726-006-0403-1</ArticleId><ArticleId IdType="pmc">PMC7087620</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>FEBS Lett. 1993 Apr 26;321(2-3):247-50</Citation><ArticleIdList><ArticleId IdType="pubmed">8477857</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 Oct 10;302(5643):276-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12958366</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>EMBO J. 1999 Feb 15;18(4):793-803</Citation><ArticleIdList><ArticleId IdType="pubmed">10022822</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Proteome Res. 2004 Sep-Oct;3(5):1069-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15473697</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Glycobiology. 2003 Feb;13(2):51-71</Citation><ArticleIdList><ArticleId IdType="pubmed">12626407</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Proteome Res. 2005 Sep-Oct;4(5):1681-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16212421</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Proteome Res. 2004 Jul-Aug;3(4):856-61</Citation><ArticleIdList><ArticleId IdType="pubmed">15359741</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2006 Jun 9;344(3):1048-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16647045</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Glycobiology. 2005 Apr;15(4):347-59</Citation><ArticleIdList><ArticleId IdType="pubmed">15563715</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Med Chem. 2005 May;1(3):209-13</Citation><ArticleIdList><ArticleId IdType="pubmed">16787316</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Neuron. 1995 Mar;14(3):651-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7695912</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>FEBS Lett. 2000 Mar 31;470(3):249-56</Citation><ArticleIdList><ArticleId IdType="pubmed">10745077</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2003 Aug 15;308(1):148-51</Citation><ArticleIdList><ArticleId IdType="pubmed">12890493</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Annu Rev Biophys Biomol Struct. 1999;28:181-204</Citation><ArticleIdList><ArticleId IdType="pubmed">10410800</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Comput Aided Mol Des. 2001 May;15(5):411-28</Citation><ArticleIdList><ArticleId IdType="pubmed">11394736</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 1999 Jun 7;259(2):420-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10362524</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Apr 9;316(3):636-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15033447</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Med Chem. 2004 Aug;11(16):2105-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15279552</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Jun 25;319(2):433-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15178425</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2005 May 27;331(1):56-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15845357</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81</Citation><ArticleIdList><ArticleId IdType="pubmed">16081529</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26</Citation><ArticleIdList><ArticleId IdType="pubmed">11259830</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2002 Apr 5;292(3):702-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11922623</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Protein Pept Sci. 2005 Oct;6(5):399-411</Citation><ArticleIdList><ArticleId IdType="pubmed">16248792</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country><settlement><li>Tianjin</li></settlement></list><tree><noCountry><name sortKey="Chou, K C" sort="Chou, K C" uniqKey="Chou K" first="K-C" last="Chou">K-C Chou</name><name sortKey="Du, Q S" sort="Du, Q S" uniqKey="Du Q" first="Q-S" last="Du">Q-S Du</name><name sortKey="Li, A X" sort="Li, A X" uniqKey="Li A" first="A-X" last="Li">A-X Li</name><name sortKey="Wei, D Q" sort="Wei, D Q" uniqKey="Wei D" first="D-Q" last="Wei">D-Q Wei</name><name sortKey="Zhao, K" sort="Zhao, K" uniqKey="Zhao K" first="K" last="Zhao">K. Zhao</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Wang, S Q" sort="Wang, S Q" uniqKey="Wang S" first="S-Q" last="Wang">S-Q Wang</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C36 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001C36 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:16998715
|texte= Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:16998715" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |